Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

Medicina Clínica (English Edition) - Tập 156 - Trang 589-594 - 2021
Pau Llàcer1, Mari Ángeles Gallardo2, Patricia Palau3, Mari Carmen Moreno4, Carla Castillo5, Cristina Fernández4, Rafael de la Espriella3, Anna Mollar3, Enrique Santas3, Gema Miñana3,6, Luis Manzano1,7, Antoni Bayés-Genís8, Julio Núñez3,6
1Servicio de Medicina Interna, Hospital Universitario Ramón y Cajal, Madrid, Spain
2Servicio de Medicina Interna, Hospital de Valme, Sevilla, Spain
3Servicio de Cardiología, Hospital Clínico Universitario, Universitat de València, INCLIVA, Valencia, Spain
4Servicio de Medicina Interna, Hospital de Manises, Valencia, Spain
5Servicio de Cardiología, Hospital de Manises, Valencia, Spain
6CIBER Cardiovascular, Madrid, Spain
7Departamento de Medicina y Especialidades Médicas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, IRYCIS, Madrid, Spain
8Servicio de Cardiología, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Tài liệu tham khảo

Yancy, 2004, Quality of care and outcomes in acute decompensated heart failure: the ADHERE registry, Curr Heart Fail Rep., 1, 121, 10.1007/s11897-004-0021-8

Peacock, 2010, Current techniques of fluid status assessment, Contrib Nephrol, 164, 128, 10.1159/000313726

Gheorghiade, 2010, Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine, Eur J Heart Fail., 12, 423, 10.1093/eurjhf/hfq045

Mullens, 2019, The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail., 21, 137, 10.1002/ejhf.1369

Llàcer, 2019, Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment, Med Clin (Barc)., 152, 266, 10.1016/j.medcli.2018.08.020

Miñana, 2010, CA125 and immunoinflammatory activity in acute heart failure, Int J Cardiol., 145, 547, 10.1016/j.ijcard.2010.04.081

Núñez, 2007, Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?, Heart., 93, 716, 10.1136/hrt.2006.096016

Núñez, 2010, Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure, Eur Heart J., 31, 1752, 10.1093/eurheartj/ehq142

Núñez, 2019, A randomized controlled trial on carbohydrate antigen 125-guided diuretic treatment versus usual care in patients with acute heart failure and renal dysfunction, Am J Med.

Núñez, 2016, Carbohydrate antigen-125-guided therapy in acute heart failure: CHANCE-HF: a randomized study, JACC Heart Fail., 4, 833, 10.1016/j.jchf.2016.06.007

Ponikowski, 2016, Eur Heart J., 37, 2129, 10.1093/eurheartj/ehw128

Lang, 2005, J Am Soc Echocardiogr., 18, 1440, 10.1016/j.echo.2005.10.005

Kouris, 2005, The significance of CA 125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters, Eur J Heart Fail., 7, 199, 10.1016/j.ejheart.2004.07.015

Miñana, 2020, Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure, Eur Heart J Acute Cardiovasc Care., 10.1177/2048872620908033

Yilmaz, 2011, Plasma CA-125 level is related to both sides of the heart: a retrospective analysis, Int J Cardiol., 149, 80, 10.1016/j.ijcard.2009.12.003

Yilmaz, 2011, Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease, Clin Cardiol., 34, 244, 10.1002/clc.20868

Josa-Laorden, 2016, Prognostic value of measuring the diameter and inspiratory collapse of the inferior vena cava in acute heart failure, Rev Clin Esp., 216, 183

Mueller, 2019, Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations, Eur J Heart Fail., 21, 715, 10.1002/ejhf.1494

Kang, 2015, Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF, Heart., 101, 1881, 10.1136/heartjnl-2015-307782

Lankeit, 2014, Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism, Eur Respir J., 43, 1669, 10.1183/09031936.00211613

Núñez, 2017, Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure, Eur Heart J Acute Cardiovasc Care., 6, 685, 10.1177/2048872616649757

Felker, 2017, Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial, JAMA., 318, 713, 10.1001/jama.2017.10565

Thông tin
Thông tin xuất bản

Medicina Clínica (English Edition)

Tập 156

589-594

Thông tin tác giả